We understand that the time to market for your biologics can make all the difference to patients waiting for valuable therapeutic options. For this reason, 3P´s highly experienced professionals are constantly focused on developing scalable, efficient processes that can be smoothly transferred to our larger scales in order to minimize time-to-market. The time “spent” in our laboratory is an investment for the future of your project and our development platforms result in robust, scalable and well-controlled processes with excellent reproducibility when facing non-clinical and clinical phases. Our dedicated team of scientists and analysts have the skills and knowledge to develop processes to meet your project goals in a high-quality and cost-effective way. A unique combination of know-how, use of the latest technologies / equipment, and our team spirit allow us to effectively and efficiently work with you to drive product development forward to achieve successful commercial manufacturing.(MCB) and/or Working Cell Bank (WCB) to deliver reproducible quality and safety during commercial production.
The manufacture of mammalian biopharmaceuticals has become a major global enterprise. We are committed to working with you to drive your mammalian manufacturing to success. 3P’s manufacturing facilities provide single-use technology for cost-effective production, reducing the possibility of cross contamination and enabling faster manufacturing. As part of our one-stop-shop service, we also offer a wide variety of in-house analytical testing and release capabilities to support the quality manufacturing of your clinical or commercial-stage products.and/or Working Cell Bank (WCB) to deliver reproducible quality and safety during commercial production.